• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Factor XIII Deficiency

Factor XIII Deficiency - 9 Studies Found

Completed : A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
: Factor XIII Deficiency
: 2009-04-21
: Biological: FXIII Concentrate (Human) Doses will be guided
Completed : An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
: Factor XIII Deficiency
: 2009-07-23
: Biological: FXIII Concentrate (Human) (FXIII) Doses will b
Completed : A Study of the Use of Factor XIII Concentrate in Patients With Inherited FXIII Deficiency
: Factor XIII Deficiency
: 2009-04-16
: Biological: FXIII Concentrate (Human) Subjects will receive approximately 40 U/kg of FXIII every 28 days
Completed : Clinical Trial of Factor XIII (FXIII) Concentrate
:
  • Hemophilia
  • Factor XIII Deficiency

: 2008-03-17
: Drug: Fibrogammin P Prophylaxis treatment
Completed : Wound Healing Abnormalities in Major Abdominal Surgery
:
  • Impaired Wound Healing
  • Factor XIII Deficiency

: 2008-08-14
Completed : Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725
:
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency

: 2009-09-15
: Drug: catridecacog Monthly administration of recombinant factor XIII as preventative treatment of bleedi
Completed : Factor XIII and Pulmonary Embolism in Neurosurgical Patients
:
  • Brain Tumor
  • Vascular Lesion
  • Factor X
    : 2010-04-16
Completed : Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency
:
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency

: 2003-03-18
: Drug: catridecacog Single doses of rFXIII administered intravenously (IV) to two subjects in each of the
Completed : Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency
:
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency

: 2008-07-07
: Drug: catridecacog 35 IU/kg body weight, i.v. administration, once every 4 weeks
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.